In previous studies, DEX proved to suppress cell invasion in bladder cancer [68], inhibited hypoxia-induced EMT in colon cancer cells [69], and reduced TGF-β-induced EMT in non-malignant cells [70]. Here, TGFB1 is linked to urinary bladder carcinoma.